Jean Pierre Millon

CIK 1190016 · last filed 2024-11-25

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$10.60M

Companies

Total Filings

Lifetime Open-Market Net

-$4.39M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CVS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CVS	Director	112,217	$94.48	$10.60M	-$4.39M	48	2024-11-25
CYPRESS BIOSCIENCE INC (CYPB) Delisted	Director	—	—	—	$0	1	2010-01-06
CYPRESS BIOSCIENCE INC (NSTR) Delisted	Director	—	—	—	$0	4	2009-01-07
CAREMARK RX INC (CMX) Delisted	Director	19,350	—	—	$0	2	2007-02-16

Recent Filings · Page 5 of 7

62 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2008-05-08	CVS	Grant (A)	+7,130	$296.1K	EDGAR
2008-03-06	CVS	Grant (A)	+73	$2.9K	EDGAR
2008-02-13	CVS	Grant (A)	+24	$969	EDGAR
2008-01-29	CYPRESS BIOSCIENCE INC (NSTR) Delisted	Grant (A)	—	$0	EDGAR
2008-01-10	CVS	Grant (A)	+132	$4.9K	EDGAR
2008-01-04	CYPRESS BIOSCIENCE INC (NSTR) Delisted	Grant (A)	—	$0	EDGAR
2007-11-15	CVS	Mixed	—	-$938.5K	EDGAR
2007-11-08	CVS	Grant (A)	+851	$35.4K	EDGAR
2007-10-31	CVS	Grant (A)	+23	$962	EDGAR
2007-10-16	—	Sell (S)	—	$0

Showing 41–50 of 62

Prev Page 5 of 7 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.